We are an independent and non-profit international group of Multiple Sclerosis experts dedicated to improving Multiple Sclerosis patient care.
Sanofi is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Sanofi aims to advance new therapies, demonstrating its commitment to making a positive impact on the lives of patients around the world.
Roche is the world’s number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in Roche’s product pipeline are biopharmaceuticals, enabling to deliver better-targeted therapies.
Merck is a vibrant team of specialists in Healthcare, Life Science and Performance Materials. Merck shares a love of science and a passion for technology and provides scientists with lab materials, technologies and services to make research and biotech production simpler, faster and safer.
Minimum two MS experts collaborate to produce an educational slide deck. These slide decks are presented (live) to ParadigMS members, peer reviewed and updated.
The slide decks are published on the ParadigMS website “on behalf of ParadigMS”.
Based on the slide decks, publications are produced. These publications are peer reviewed and published as consensus publications.
Regional (fe: Scandinavian countries, Benelux, …) or national events where state-of-the-art science is transferred to general neurologists and other care givers (nurses, etc) that are confronted with MS in their day to day practice.
Webinars can complement the educational events.
The educational slide decks, events and webinars can be important building blocks of accredited educational programs.